Arrowhead Pharmaceuticals Statistics

Total Valuation

LON:0HI3 has a market cap or net worth of GBP 1.60 billion. The enterprise value is 1.34 billion.

Market Cap	1.60B
Enterprise Value	1.34B

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	138.10M
Shares Outstanding	n/a
Shares Change (YoY)	+13.90%
Shares Change (QoQ)	+7.72%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	120.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.79
PB Ratio	3.02
P/TBV Ratio	3.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.01
EV / Sales	3.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	180.24

Financial Position

The company has a current ratio of 5.15, with a Debt / Equity ratio of 1.08.

Current Ratio	5.15
Quick Ratio	4.98
Debt / Equity	1.08
Debt / EBITDA	n/a
Debt / FCF	77.17
Interest Coverage	-1.88

Financial Efficiency

Return on equity (ROE) is -26.22% and return on invested capital (ROIC) is -6.39%.

Return on Equity (ROE)	-26.22%
Return on Assets (ROA)	-5.86%
Return on Invested Capital (ROIC)	-6.39%
Return on Capital Employed (ROCE)	-8.76%
Revenue Per Employee	692,917
Profits Per Employee	-182,973
Employee Count	609
Asset Turnover	0.43
Inventory Turnover	n/a

Taxes

In the past 12 months, LON:0HI3 has paid 1.86 million in taxes.

Income Tax	1.86M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.08% in the last 52 weeks. The beta is 0.95, so LON:0HI3's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-40.08%
50-Day Moving Average	14.17
200-Day Moving Average	18.35
Relative Strength Index (RSI)	49.17
Average Volume (20 Days)	960

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.21

Income Statement

In the last 12 months, LON:0HI3 had revenue of GBP 421.99 million and -111.43 million in losses. Loss per share was -0.88.

Revenue	421.99M
Gross Profit	421.99M
Operating Income	-91.76M
Pretax Income	-117.86M
Net Income	-111.43M
EBITDA	-75.41M
EBIT	-91.76M
Loss Per Share	-0.88

Full Income Statement

Balance Sheet

The company has 847.76 million in cash and 573.15 million in debt, giving a net cash position of 274.61 million.

Cash & Cash Equivalents	847.76M
Total Debt	573.15M
Net Cash	274.61M
Net Cash Per Share	n/a
Equity (Book Value)	529.58M
Book Value Per Share	3.83
Working Capital	707.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 47.33 million and capital expenditures -39.90 million, giving a free cash flow of 7.43 million.

Operating Cash Flow	47.33M
Capital Expenditures	-39.90M
Free Cash Flow	7.43M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -21.74% and -26.41%.

Gross Margin	100.00%
Operating Margin	-21.74%
Pretax Margin	-27.93%
Profit Margin	-26.41%
EBITDA Margin	-17.87%
EBIT Margin	-21.74%
FCF Margin	1.76%

Dividends & Yields

LON:0HI3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.90%
Shareholder Yield	n/a
Earnings Yield	-6.97%
FCF Yield	0.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HI3 has an Altman Z-Score of 1.37 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.37
Piotroski F-Score	3